top of page
All Hands In

OUR PARTNERS
REDEFINING DRUG DELIVERY
 

Anodyne is actively expanding its pipeline through both internal clinical development and strategic external partnerships to maximize the commercial potential of its cutting-edge drug delivery platform. We are committed to collaborating with partners interested in commercializing products utilizing Anodyne’s HeroPatch™ technology.
 

The HeroPatch offers substantial advantages for pharmaceutical partners looking to achieve:

Increased Patient Adherence

  • Transdermally deliver up to 30mg/patch

  • Optimized to deliver: monoclonal antibodies, therapeutic peptides and nucleic acid agents

  • Reduced side effects

  • Lower discontinuation rates

Expanded Market Share

  • Eliminate cold chain distribution, reducing the amount of plastic/patient by 20x and the supply chain cost by 10x

  • Scalable manufacturing process

  • Life cycle management

Enabling Formulation Technology

  • Solid-state stability to injectable therapies

  • Tunable shape/size/dosage to address specific needs

  • Potential for combination therapies in a single patch

Understanding the importance and mutual benefits of teamwork, Anodyne believes that patients are the true beneficiaries of these collaborative efforts. We welcome opportunities to explore potential partnerships that can drive innovation and deliver value to both parties.


Contact Us

bottom of page